Casein phosphopeptide-amorphous calcium phosphate: the scientific evidence.
Reynolds
E C
EC
Cooperative Research Centre for Oral Health Science, School of Dental Science, Bio21 Institute of Molecular Science and Biotechnology, The University of Melbourne, Victoria 3010, Australia. e.reynolds@unimelb.edu.au
D000818:Animals; D002327:Cariostatic Agents / Q000627:therapeutic use*; D002364:Caseins / Q000737:chemistry / Q000627:therapeutic use*; D003731:Dental Caries / Q000517:prevention & control*; D004338:Drug Combinations; D005459:Fluorides / Q000627:therapeutic use; D006801:Humans; D053761:Nanocomposites; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D014089:Tooth Remineralization / Q000379:methods*
D002327:Cariostatic Agents; D002364:Caseins; D004338:Drug Combinations; C447032:casein phosphopeptide-amorphous calcium phosphate nanocomplex; D005459:Fluorides